These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11758557)

  • 1. FDAMA update.
    Suydam LA; Elder DK
    Food Drug Law J; 1999; 54(1):21-33. PubMed ID: 11758557
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA's implementation of FDAMA: an interim balance sheet.
    Suydam LA; Kubic MJ
    Food Drug Law J; 2001; 56(2):131-5. PubMed ID: 12022190
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA Amendments Act: reauthorization of the FDA.
    von Eschenbach AC
    Food Drug Law J; 2008; 63(2):579-84. PubMed ID: 18561478
    [No Abstract]   [Full Text] [Related]  

  • 4. Ganging up on the FDA.
    Stone PH
    Natl J (Wash); 1995 Feb; 27(7):410-4. PubMed ID: 10140321
    [No Abstract]   [Full Text] [Related]  

  • 5. Remarks of the Commissioner of Food and Drugs.
    Henney JE
    Food Drug Law J; 2000; 55(1):1-4. PubMed ID: 12269355
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulator under siege.
    Wadman M
    Nature; 2007 Dec; 450(7173):1143. PubMed ID: 18097370
    [No Abstract]   [Full Text] [Related]  

  • 7. Balancing the books.
    Roehr B; von Eschenback A
    BMJ; 2007 Sep; 335(7618):471. PubMed ID: 17823170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the Center for Devices and Radiological Health.
    Jacobson ED
    Food Drug Law J; 2000; 55(2):185-91. PubMed ID: 12269363
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA's FDAMA accomplishments--one year after enactment.
    Ann Pharmacother; 1999 Jan; 33(1):134. PubMed ID: 9972401
    [No Abstract]   [Full Text] [Related]  

  • 10. Remarks of the Commissioner of Food and Drugs.
    Henney JE
    Food Drug Law J; 1999; 54(1):1-3. PubMed ID: 11794304
    [No Abstract]   [Full Text] [Related]  

  • 11. A changed FDA?
    Lancet; 2008 Aug; 372(9637):420. PubMed ID: 18692698
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory watch: FDA PDUFA goals missed.
    Hay M
    Nat Rev Drug Discov; 2009 Jan; 8(1):10. PubMed ID: 19116619
    [No Abstract]   [Full Text] [Related]  

  • 13. New FDA Commissioner sees challenges, opportunities.
    Lewis C
    FDA Consum; 2003; 37(1):9. PubMed ID: 12625298
    [No Abstract]   [Full Text] [Related]  

  • 14. Universal Management, Abbott, Wyeth, Shering-Plough, and ... : restitution and disgorgement find another home at the Food and Drug Administration.
    Blumberg EM
    Food Drug Law J; 2003; 58(2):169-90. PubMed ID: 12866551
    [No Abstract]   [Full Text] [Related]  

  • 15. Prepared remarks: Lester M. Crawford, Jr., D.V.M., Ph.D., Deputy Commissioner, U.S. Food and Drug Administration.
    Food Drug Law J; 2002; 57(2):231-6. PubMed ID: 12436986
    [No Abstract]   [Full Text] [Related]  

  • 16. Anchors away: the Food and Drug Administration's use of disgorgement abandons legal moorings.
    Vodra WW; Levine AN
    Food Drug Law J; 2004; 59(1):1-30. PubMed ID: 15190923
    [No Abstract]   [Full Text] [Related]  

  • 17. The authority of a court to order disgorgement for violations of the Current Good Manufacturing Practices requirement of the Federal Food, Drug, and Cosmetic Act.
    King E; Walsh EM
    Food Drug Law J; 2003; 58(2):149-68. PubMed ID: 12866550
    [No Abstract]   [Full Text] [Related]  

  • 18. Can FDA seek restitution or disgorgement?
    Gibbs JN; Fleder JR
    Food Drug Law J; 2003; 58(2):129-47. PubMed ID: 12866549
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA embraces risk-management approach.
    Fox JL
    Nat Biotechnol; 2003 Oct; 21(10):1120-1. PubMed ID: 14520383
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA science: protecting America's health.
    Bren L
    FDA Consum; 2003; 37(2):30-5. PubMed ID: 12715768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.